Grail (NASDAQ:GRAL) Hits New 52-Week High – Here’s What Happened

Grail, Inc. (NASDAQ:GRAL) shares hit a new 52-week high during trading on Friday . The company traded as high as $31.59 and last traded at $31.51, with a volume of 1479432 shares trading hands. The stock had previously closed at $26.67.

Wall Street Analyst Weigh In

Several research firms have commented on GRAL. Morgan Stanley began coverage on shares of Grail in a research note on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 target price on the stock. Wolfe Research began coverage on Grail in a research report on Friday, November 15th. They set a “peer perform” rating on the stock. Finally, Guggenheim started coverage on shares of Grail in a research report on Thursday, October 17th. They set a “neutral” rating for the company.

Grail Price Performance

The company has a fifty day simple moving average of $19.76 and a 200-day simple moving average of $16.48.

Grail (NASDAQ:GRAL) last announced its earnings results on Tuesday, November 12th. The company reported ($3.94) earnings per share (EPS) for the quarter. The firm had revenue of $28.65 million during the quarter. On average, equities research analysts forecast that Grail, Inc. will post -65.16 EPS for the current fiscal year.

Insider Buying and Selling at Grail

In other Grail news, CFO Aaron Freidin sold 30,452 shares of the business’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $14.02, for a total transaction of $426,937.04. Following the sale, the chief financial officer now directly owns 268,277 shares of the company’s stock, valued at $3,761,243.54. The trade was a 10.19 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Institutional Trading of Grail

Several hedge funds and other institutional investors have recently modified their holdings of the business. abrdn plc acquired a new position in Grail during the fourth quarter valued at $3,768,000. Douglas Lane & Associates LLC acquired a new position in shares of Grail in the 4th quarter valued at about $3,034,000. Slow Capital Inc. purchased a new stake in shares of Grail in the fourth quarter worth approximately $2,379,000. 180 Wealth Advisors LLC acquired a new stake in shares of Grail during the fourth quarter worth approximately $1,681,000. Finally, Moloney Securities Asset Management LLC acquired a new stake in shares of Grail during the fourth quarter worth approximately $559,000.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.